ieso Digital Health Inc.

Ieso Digital Health Ltd. provides innovative digital mental health solutions that enhance therapeutic interventions through technology, significantly improving patient access to personalized mental healthcare services. Founded in 2000, Ieso Digital Health Ltd. is based in Cambridge, UK, and specializes in digital mental health solutions.

The company raised GBP 39. 30 mn in Series B funding on October 19, 2021, led by Morningside Venture Partners, with participation from Sony Ventures, among others. The founding CEO, Barnaby Perks, has a background in leading digital health initiatives. Ieso Group specializes in delivering digital mental health solutions that integrate evidence-based therapeutic interventions with advanced technology.

Their core offerings include one-to-one digital therapy programs that leverage AI and machine learning to personalize treatments based on deidentified patient data, enhancing accessibility and effectiveness in mental healthcare. Target clientele includes health systems, providers, and payers, primarily within the UK and expanding to other markets, such as the US. With a focus on scalable digital products, Ieso has developed a unique outcomes-indexed mental health dataset, positioning itself as a leader in data-driven mental health innovation. In 2024, Ieso Group reported a revenue of GBP 9,703 and EBITDA of GBP 13,627.

Ieso generates revenue primarily through partnerships and collaborations with health systems and payers, offering subscription-based access to their digital therapy services, including their flagship service, Ieso Therapy Service. Following the GBP 39. 30 mn Series B funding round in October 2021, Ieso plans to extend its commercial teams into the US and target co-development and distribution partnerships that facilitate scalable market access. This funding will support their strategy to develop new products and enhance their presence in international markets.